| Biological properties of extracellular vesicles and their physiological functions | Journal of Extracellular Vesicles | 2015 | 2.6K |
| Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper | Journal of Extracellular Vesicles | 2015 | 722 |
| Genetic Landscape and Biomarkers of Hepatocellular Carcinoma | Gastroenterology | 2015 | 695 |
| Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial | Lancet Oncology, The | 2015 | 553 |
| Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study | Lancet, The | 2015 | 539 |
| Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline | Endoscopy | 2015 | 434 |
| Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid | Gastroenterology | 2015 | 381 |
| Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis | Hepatology | 2015 | 342 |
| Sustained proliferation in cancer: Mechanisms and novel therapeutic targets | Seminars in Cancer Biology | 2015 | 321 |
| European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases | Journal of Crohn's and Colitis | 2015 | 278 |
| DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma | Hepatology | 2015 | 237 |
| Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy | Gastroenterology | 2015 | 235 |
| Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? | American Journal of Gastroenterology | 2015 | 225 |
| The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure | Journal of Hepatology | 2015 | 207 |
| Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis | Hepatology | 2015 | 207 |
| Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease | Gastroenterology | 2015 | 198 |
| Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation | Hepatology | 2015 | 183 |
| Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma | Nature Communications | 2015 | 183 |
| Designing a broad-spectrum integrative approach for cancer prevention and treatment | Seminars in Cancer Biology | 2015 | 179 |
| Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging | American Journal of Gastroenterology | 2015 | 177 |
| Liver cancer: Approaching a personalized care | Journal of Hepatology | 2015 | 175 |
| Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome | Scientific Reports | 2015 | 173 |
| Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis | Hepatology | 2015 | 159 |
| Mitochondrial Respiration Controls Lysosomal Function during Inflammatory T Cell Responses | Cell Metabolism | 2015 | 154 |
| Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants | Clinical Gastroenterology and Hepatology | 2015 | 151 |
